Gleevec - Drug Details
๐Ÿ“Š Estimates Gleevec Dialyzability By Different_Modalities

Gleevec

Complete Drug Information

Drug Name
Gleevec
Trade Names
Gleevec, Glivec
Pregnancy Category
AU: D
Bioavailability
98%
Routes of Administration
Oral
Protein Binding
95%%
Metabolism
Liver (mainly CYP3A4-mediated)
Elimination
18 h (imatinib)40 h (active metabolite)
Excretion
Fecal (68%) and kidney (13%)
Formula
C29H31N7O
Molar Mass
493.615
Drug Class
Tyrosine kinase inhibitor
Volume of Distribution
C29H31N7O

๐Ÿคฐ Pregnancy Category Information

Category: AU: D

Drugs which have caused, are suspected to have caused, or may be expected to cause an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects.